BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Clinical Secondary Packaging and Labelling licence, to our German facility.

The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator Sourcing Division.

Clinical Secondary Packaging and Labelling Services:

• Packaging & Label Design, Randomisation and Language Translations
• Controlled Room Temperature and Cold Chain Packaging and Labelling
• Global Storage, Distribution, Returns and Destruction
• JIT (Just In Time) and On-Demand Labelling
• QP Advice, Declaration and Certification

Our Clinical Secondary Packaging and Labelling service culminates in the creation of patient kits, which are distributed through our Global Storage and Distribution network. This ensures delivery to the right place, at the right time and in the right condition, to patients’ participating in clinical trials across the globe.

“This is a great achievement for our Bavarian facility and testament to our excellent team. Our new packaging and labelling capabilities will complement our additional services and further strengthen our clinical trial supply offering”.

Simon Magness, Managing Director BAP Pharma GmbH.